Richard G. Leduc
Sherbrooke, QC J1H5N4, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications
TMPRSS2 inhibitors with broad-spectrum efficacy against SARS-CoV-2 (JN.1) and influenza A (H1N1) viruses protect mice from influenza A infection.
Journal: Emerging microbes & infections
Published: January 30, 2026
Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy via C-Terminal Peptide Engineering and Allosteric Site Targeting.
Journal: Journal of medicinal chemistry
Published: January 16, 2026
Profiling circular RNAs in amniotic fluid and fetal lungs from congenital diaphragmatic hernia cases: insights into potential prognostic and diagnostic applications.
Journal: Pediatric surgery international
Published: January 09, 2026
Structure-Guided Optimization of Selective Covalent Reversible Peptidomimetic Inhibitors Targeting TMPRSS6.
Journal: Journal of medicinal chemistry
Published: December 05, 2025
Structural insights into frog skin-derived cyclic peptides as selective matriptase inhibitors.
Journal: European journal of medicinal chemistry
Published: August 30, 2025
Decoding ADGRE5: How Proteolytic Cleavage and Mechanical Forces Unleash Cellular Signals.
Journal: Cells
Published: July 18, 2025
Adhesion GPCR ADGRL1/Latrophilin-1 mobilizes β-arrestins as a prerequisite for endosomal restriction of G protein activation and splice-dependent scaffolds.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: April 17, 2025
Adhesion GPCR ADGRL1/Latrophilin-1 mobilizes β-arrestins as a prerequisite for endosomal restriction of G protein activation and splice-dependent scaffolds.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: April 17, 2025
From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 Variants.
Journal: Journal of medicinal chemistry
Published: March 31, 2025
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 20, 2025
Optimizing the pharmacokinetics and selectivity of TMPRSS2 inhibitors.
Journal: European journal of medicinal chemistry
Published: February 18, 2025
Last Updated: 09/26/2026